JCR Pharmaceuticals Co., Ltd.
4552.T · JPX
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | ¥13 | ¥19 | ¥13 | ¥31 |
| Short-Term Investments | ¥0 | ¥0 | ¥0 | ¥0 |
| Receivables | ¥12 | ¥15 | ¥11 | ¥16 |
| Inventory | ¥22 | ¥21 | ¥19 | ¥15 |
| Other Curr. Assets | ¥4 | ¥3 | ¥5 | ¥1 |
| Total Curr. Assets | ¥51 | ¥58 | ¥48 | ¥62 |
| Property Plant & Equip (Net) | ¥37 | ¥30 | ¥33 | ¥27 |
| Goodwill | ¥0 | ¥0 | ¥0 | ¥0 |
| Intangibles | ¥3 | ¥3 | ¥4 | ¥3 |
| Long-Term Investments | ¥10 | ¥9 | ¥9 | ¥2 |
| Tax Assets | ¥3 | ¥0 | ¥1 | ¥2 |
| Other NC Assets | ¥1 | ¥2 | ¥1 | ¥1 |
| Total NC Assets | ¥54 | ¥45 | ¥47 | ¥35 |
| Other Assets | ¥0 | ¥0 | ¥0 | ¥0 |
| Total Assets | ¥105 | ¥102 | ¥95 | ¥97 |
| Liabilities | – | – | – | – |
| Payables | ¥1 | ¥1 | ¥2 | ¥1 |
| Short-Term Debt | ¥26 | ¥9 | ¥17 | ¥15 |
| Tax Payable | ¥0 | ¥2 | ¥0 | ¥6 |
| Deferred Revenue | ¥0 | ¥2 | ¥4 | ¥12 |
| Other Curr. Liab. | ¥16 | ¥16 | ¥12 | ¥12 |
| Total Curr. Liab. | ¥44 | ¥30 | ¥36 | ¥42 |
| LT Debt | ¥12 | ¥14 | ¥6 | ¥3 |
| Deferred Rev, NC | ¥0 | -¥0 | -¥0 | -¥0 |
| Deferred Tax Liab, NC | ¥1 | ¥0 | ¥0 | ¥0 |
| Other NC Liab. | ¥1 | ¥1 | ¥1 | ¥1 |
| Total NC Liab. | ¥13 | ¥16 | ¥7 | ¥4 |
| Other Liabilities | ¥0 | -¥0 | ¥0 | ¥0 |
| Cap. Leases | ¥0 | ¥0 | ¥0 | ¥0 |
| Total Liabilities | ¥57 | ¥46 | ¥43 | ¥46 |
| Equity | – | – | – | – |
| Pref Stock | ¥0 | ¥0 | ¥0 | ¥50 |
| Common Stock | ¥9 | ¥9 | ¥9 | ¥9 |
| Retained Earnings | ¥31 | ¥37 | ¥34 | ¥33 |
| AOCI | ¥1 | ¥2 | ¥1 | ¥1 |
| Other Equity | ¥0 | ¥0 | ¥0 | ¥0 |
| Total Equity | ¥47 | ¥56 | ¥52 | ¥51 |
| Supplemental Information | – | – | – | – |
| Minority Interest | ¥0 | ¥0 | ¥0 | ¥0 |
| Total Liab. & Tot. Equity | ¥105 | ¥102 | ¥95 | ¥97 |
| Net Debt | ¥25 | ¥5 | ¥10 | -¥13 |